Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects (Q43706155)

26 November 2017

Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects (English)

1 reference

26 November 2017

heart rate variability

0 references

1 reference

A C Nóbrega

1

1 reference

26 November 2017

A F dos Reis

2

1 reference

26 November 2017

R S Moraes

3

1 reference

26 November 2017

B G Bastos

4

1 reference

26 November 2017

E L Ferlin

5

1 reference

26 November 2017

J P Ribeiro

6

1 reference

26 November 2017

1 February 2001

1 reference

Clinical Autonomic Research

26 November 2017

1 reference

26 November 2017

11

1 reference

26 November 2017

1

1 reference

26 November 2017

11-17

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02317797

26 November 2017

0 references

cites work

Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

The long-term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

Autonomic neural influences on the dysrhythmias resulting from myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02317797

Opposing central and peripheral effects of atropine on parasympathetic cardiac control

21 January 2018

1 reference

12 December 2020

Decreased heart rate variability and its association with increased mortality after acute myocardial infarction

1 reference

12 December 2020

The role of enhanced vagal activity on ischemic ventricular tachycardia: Pharmacologic basis of inefficiency

1 reference

12 December 2020

Vagal stimulation after myocardial infarction: accentuating the positive

1 reference

12 December 2020

Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis

1 reference

12 December 2020

Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction

1 reference

12 December 2020

Reduction of QTc interval dispersion. Potential mechanism of cardiac protection of pyridostigmine bromide

1 reference

12 December 2020

Muscarinic receptor stimulation with edrophonium hydrochloride does not elevate ventricular fibrillation thresholds in humans

1 reference

12 December 2020

Electrical stability of acutely ischemic myocardium. Influences of heart rate and vagal stimulation

1 reference

12 December 2020

Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control

1 reference

12 December 2020

Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies

1 reference

12 December 2020

Influence of heart rate on mortality after acute myocardial infarction

1 reference

12 December 2020

Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction

1 reference

12 December 2020

Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors

1 reference

12 December 2020

Influence of transdermal scopolamine on cardiac sympathovagal interaction after acute myocardial infarction

1 reference

12 December 2020

Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials

1 reference

12 December 2020

Autonomic nervous system adaptations to short-term exercise training

1 reference

12 December 2020

Resting and reflex heart rate responses during cholinergic stimulation with pyridostigmine in humans

1 reference

12 December 2020

Cholinergic stimulation with pyridostigmine blunts the cardiac responses to mental stress.

1 reference

12 December 2020

Three-dimensional return map: a new tool for quantification of heart rate variability

1 reference

12 December 2020

Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification

1 reference

12 December 2020

Termination of ventricular tachycardia by an increase in cardiac vagal drive

1 reference

12 December 2020

Low doses of scopolamine increase cardiac vagal tone in the acute phase of myocardial infarction

1 reference

12 December 2020

Exercise training after experimental myocardial infarction increases the ventricular fibrillation threshold before and after the onset of reinfarction in the isolated rat heart

1 reference

12 December 2020

Pyridostigmine blunts the increases in myocardial oxygen demand elicited by the stimulation of the central nervous system in anesthetized rats.

1 reference

12 December 2020

Components of heart rate variability--what they really mean and what we really measure

1 reference

12 December 2020

Modulation of the dose-dependent effects of atropine by low-dose pyridostigmine: quantification by spectral analysis of heart rate fluctuations in healthy human beings

1 reference

12 December 2020

Acetylcholinesterase inhibitor, pyridostigmine bromide, reduces skin blood flow in humans

1 reference

12 December 2020

Exercise training confers anticipatory protection from sudden death during acute myocardial ischemia

1 reference

12 December 2020

Parasympathetic dysfunction as a risk factor in myocardial infarction: what is the treatment?

1 reference

12 December 2020

Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction

1 reference

12 December 2020

Bradycardia produced by pyridostigmine and physostigmine.

1 reference

12 December 2020

Sympathetic nervous system representation in time and frequency domain indices of heart rate variability

1 reference

12 December 2020

Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure

1 reference

12 December 2020

Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction.

1 reference

12 December 2020

The effects of psychological stress and vagal stimulation with morphine on vulnerability to ventricular fibrillation (VF) in the conscious dog.

1 reference

12 December 2020

Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease

1 reference

12 December 2020

Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine

1 reference

12 December 2020

Pyridostigmine bromide does not alter thermoregulation during exercise in cold air

1 reference

12 December 2020

How important is heart rate?

1 reference

12 December 2020

Pharmacokinetics and oral bioavailability of pyridostigmine in man

1 reference

12 December 2020

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

1 reference

12 December 2020

Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction

1 reference

12 December 2020

Exercise stress testing in healthy subjects during cholinergic stimulation after a single dose of pyridostigmine

1 reference

12 December 2020

Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction.

1 reference

12 December 2020

Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine.

1 reference

12 December 2020

Effect of partial arrhythmia suppression with amiodarone on heart rate variability of patients with congestive heart failure

1 reference

12 December 2020

Cholinergic stimulation with pyridostigmine, hemodynamic and echocardiographic analysis in healthy subjects

1 reference

12 December 2020

Effect of a 'vagomimetic' atropine dose on canine cardiac vagal tone and susceptibility to sudden cardiac death.

1 reference

12 December 2020

Scopolamine improves autonomic balance in advanced congestive heart failure

1 reference

12 December 2020

Measurement of acetylcholinesterase in erythrocytes in the field.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02317797

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference